The IMD Exclusion: A Historic Barrier to Accessing Behavioral Health Care and How States are Navigating Around It
The Institutions for Mental Diseases (IMD) exclusion has been a part of Medicaid’s rules since the program’s inception in 1965. It is a regulation...
The Dark Side of Addiction Treatment: A Closer Look at the $175 Million Billing Scheme and Fraud in the Industry
The addiction treatment industry is a critical part of the nation’s healthcare landscape, providing care to those struggling with substance abuse. However, the industry...
The Opioid Epidemic: A Complex Battle and New Insights on Prescribing Practices
In 2017, President Donald Trump declared the opioid epidemic a “public health emergency,” drawing national attention to a crisis that had been growing for...
Innovative Approaches to Behavioral Health and Addiction Treatment: How Insurers Are Stepping Up
The opioid epidemic continues to devastate communities across the United States, claiming the lives of more than 130 people daily, according to the Centers...
PursueCare’s Innovative Remote Medication-Assisted Treatment (MAT) Model: A Game Changer in Addiction Care
The opioid epidemic continues to devastate communities across the United States, with millions of people struggling with opioid use disorder (OUD) every year. Although...
The Growing Case for Medication-Assisted Treatment (MAT) in Opioid Use Disorder Recovery
As the opioid epidemic continues to devastate communities across the United States, new studies are reinforcing the vital role of Medication-Assisted Treatment (MAT) in...
